Prescribed for the Average Patient—But Are You Average? The Case for Personalized Medication Management
When a physician hands you a prescription, the instructions printed on the label represent a carefully studied recommendation—one derived from clinical trials, regulatory review, and decades of pharmacological research. Yet those same instructions were, in many cases, developed based on data from a relatively narrow segment of the population. The result is a prescribing system that works well for many patients, but may fall short for a meaningful number of others.
This is not an argument against following your doctor's guidance. Quite the opposite. It is an argument for having a more informed, more specific conversation with your healthcare provider about whether the standard dosing protocol is genuinely the right fit for your individual physiology.
How Drug Dosing Standards Are Established
The doses printed on prescription labels emerge from a structured process. Pharmaceutical manufacturers conduct clinical trials to determine what amount of a drug produces the desired therapeutic effect while minimizing adverse reactions. These trials establish a therapeutic window—a range within which the medication is considered both effective and reasonably safe.
However, the populations enrolled in these trials have historically skewed toward younger adults, often with fewer complicating health conditions than the average patient who eventually receives the prescription. Women, older adults, individuals with chronic kidney or liver disease, and people across a wide range of body weights have frequently been underrepresented. The dose that emerges from this process is, in practical terms, an educated average—a reasonable starting point, but not a guaranteed optimal fit.
The Biology Behind Individual Variation
Your body processes medications through a series of complex biological mechanisms, and no two people execute those mechanisms in exactly the same way. Several key variables can shift how a drug behaves once it enters your system.
Metabolic rate and liver enzymes. Most drugs are broken down by enzymes in the liver, particularly a family of proteins known as cytochrome P450 enzymes. Genetic variations in these enzymes cause some individuals to metabolize drugs unusually quickly—clearing the medication before it has time to work—while others process drugs more slowly, allowing concentrations to build to potentially problematic levels. This phenomenon, sometimes described in terms of being a "fast metabolizer" or "slow metabolizer," can meaningfully affect whether a standard dose is therapeutic, insufficient, or excessive.
Age-related physiological changes. As adults grow older, kidney and liver function typically decline, and the ratio of body fat to lean muscle shifts. Both factors influence how drugs are distributed and eliminated. An older adult taking the same dose as a younger counterpart may experience higher drug concentrations simply because the body is clearing the medication less efficiently. This is one reason why adverse drug reactions are disproportionately common among patients over 65.
Body weight and composition. Many dosing protocols are calculated with an average adult body weight in mind. For individuals who fall significantly above or below that benchmark, or whose body composition differs substantially from the assumed norm, the standard dose may not achieve the intended concentration in the bloodstream.
Concurrent medications and supplements. Drug interactions represent another layer of complexity. Certain medications inhibit or accelerate the same liver enzymes responsible for processing other drugs, effectively changing how much of a given prescription is active in your system at any moment. Even some common dietary supplements and foods—most famously, grapefruit—can interfere with drug metabolism in clinically significant ways.
Kidney and liver function. Because many drugs are filtered through the kidneys or processed by the liver before being eliminated, impairment in either organ can dramatically alter how a medication behaves. Patients with chronic kidney disease, for instance, often require adjusted doses to prevent accumulation to toxic levels.
The Gap Between Standard Care and Optimal Care
None of this implies that physicians are being careless when they write a standard prescription. Prescribers are working within a system designed to be safe and effective for the broadest possible patient population. The standard dose is, by design, a reasonable first approximation.
The gap that exists is not one of negligence—it is one of information. A clinician seeing a patient for a routine follow-up may not have visibility into every variable that influences drug metabolism. Patients, meanwhile, often assume that if a dose is on the label, it must be correct for them specifically. That assumption, while understandable, is not always accurate.
Pharmacogenomic testing—genetic analysis that examines how an individual's DNA influences drug metabolism—is an emerging tool that some healthcare systems are beginning to incorporate into prescribing decisions. Though not yet universally available or covered by all insurance plans, these tests can provide actionable data about how a patient is likely to respond to dozens of medications. For patients managing complex chronic conditions or those who have experienced unexpected side effects or treatment failures, a conversation with a physician about pharmacogenomic testing may be worthwhile.
What Patients Can Do—Within the Framework of Medical Guidance
The critical distinction here is between informed advocacy and self-directed dose adjustment. Altering your own prescription without medical supervision is dangerous and should not be done under any circumstances. The goal is not to second-guess your physician, but to bring more complete information into the clinical conversation.
Consider the following steps as starting points:
Document your response to medications. Keep a simple log of any side effects, changes in symptoms, or unexpected reactions following a new prescription or dose change. Concrete observations are far more useful to a clinician than general impressions.
Share your complete medication and supplement list. Every prescription, over-the-counter medication, vitamin, and herbal supplement you take should be disclosed to your prescribing physician and pharmacist. Interactions can occur in combinations that neither you nor your provider might anticipate without the full picture.
Ask about monitoring protocols. For many medications, periodic blood tests can confirm whether drug levels are within the therapeutic range. If your physician has not discussed monitoring, it is reasonable to ask whether it is appropriate for your specific prescription.
Inquire about dose optimization. If you have been taking a medication for an extended period without the expected benefit, or if side effects have been persistent, ask your provider whether your current dose has been reviewed in the context of your current weight, kidney function, or other health changes that may have occurred since the prescription was originally written.
Request a medication review. Patients managing multiple prescriptions—particularly older adults—may benefit from a comprehensive medication review conducted by a clinical pharmacist. Many healthcare systems offer this service, and it can surface interactions or redundancies that are easy to miss in a standard office visit.
A More Informed Partnership With Your Healthcare Team
The science of prescribing is advancing. Precision medicine—the broader practice of tailoring medical treatment to individual characteristics—is gradually moving from research settings into clinical practice. In the meantime, patients have a meaningful role to play in ensuring that their medication regimens are as well-suited to their individual biology as current knowledge allows.
That role is not one of skepticism toward medical authority. It is one of active, informed participation. The most effective clinical relationships are those in which patients arrive prepared with accurate information and honest questions, and in which providers have the context they need to make the best possible recommendations.
At RSB Health Institute, we believe that trusted care begins with informed patients. Understanding the limits of population-based dosing—and knowing what questions to ask—is a meaningful step toward the kind of personalized, attentive healthcare that produces better outcomes for real individuals, not statistical averages.
